Literature DB >> 29674019

Development of a new pH assisted homogeneous liquid-liquid microextraction by a solvent with switchable hydrophilicity: Application for GC-MS determination of methamphetamine.

Siamak Kiani Shahvandi1, Mohammad Hossein Banitaba2, Hamid Ahmar3.   

Abstract

In this study, a new method based on homogeneous liquid-phase microextraction was developed for the determination of methamphetamine (MA) in urine samples. Dipropylamine (DPA), as a solvent with switchable hydrophilicity, was used as the extraction solvent and can be miscible/immiscible based on variable pH values of the aqueous sample solution. The effects of operational extraction parameters such as DPA volume, temperature, the amount of added acid and base solutions, and NaCl content of the sample were investigated. Under optimal conditions the preconcentration factor, limit of detection and linearity of the method were achieved in the ranges of 98.8, 1.5 µgL-1 and 5-1500 µgL-1, respectively. Also, within-run precision, between-run precision and robustness of the method were investigated. Finally, the proposed method was successfully applied to the analysis of MA in urine sample.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dipropylamine; GC-MS determination; Homogeneous liquid–phase microextraction; Methamphetamine; Switchable hydrophilicity solvent

Mesh:

Substances:

Year:  2018        PMID: 29674019     DOI: 10.1016/j.talanta.2018.02.115

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  2 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Development of an easy and rapid analytical method for the extraction and preconcentration of chloroquine phosphate from human biofluids prior to GC-MS analysis.

Authors:  Süleyman Bodur; Sezin Erarpat; Ömer Tahir Günkara; Sezgin Bakırdere
Journal:  J Pharmacol Toxicol Methods       Date:  2021-01-24       Impact factor: 1.950

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.